Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cross-genotype immunity to hepatitis C virus.

Robert E Lanford1, Bernadette Guerra, Deborah Chavez

  • 1Department of Virology and Immunology, Southwest National Primate Research Center, Southwest Foundation for Biomedical Research, San Antonio, Texas 78227, USA. rlanford@icarus.sfbr.org

Journal of Virology
|January 15, 2004
PubMed
Summary

Hepatitis C virus (HCV) recovery in chimpanzees provides cross-genotype protection, indicating conserved epitopes are key for a universal HCV vaccine. This study demonstrates the feasibility of developing a broad-spectrum HCV vaccine.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prospective Study of Multiparametric Renal MRI for CKD Progression (AFiRM).

Kidney international reports·2026
Same author

A precision randomized trial of hepatitis C treatment support among people who inject drugs in India: The STOP-C Trial.

Journal of hepatology·2026
Same author

Fast segmentation with the NextBrain histological atlas.

Imaging neuroscience (Cambridge, Mass.)·2026
Same author

Real-Time, Inline Quantitative MRI Enabled by Scanner-Integrated Machine Learning: A Proof of Principle With NODDI.

Magnetic resonance in medicine·2026
Same author

The Dementias Platform UK PET/MR harmonisation and test-retest study: assessment of PET repeatability and reproducibility across the national network.

European journal of nuclear medicine and molecular imaging·2026
Same author

Updated hepatitis D seroprevalence among HBsAg-positive persons aged ≥6 years in the United States, National Health and Nutrition Examination Survey, 2007‒2018.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026

Area of Science:

  • Immunology
  • Virology
  • Vaccine Development

Background:

  • Hepatitis C virus (HCV) infection poses a significant global health challenge.
  • Inducing immunity to reduce chronic HCV infection incidence is a research focus.
  • Understanding immunity promoting viral recovery and its breadth against diverse HCV genotypes is crucial for vaccine development.

Purpose of the Study:

  • To investigate if recovery from a genotype 1 HCV infection protects chimpanzees against other HCV genotypes.
  • To determine if adaptive immunity against HCV is broad enough to overcome intergenotype antigenic diversity.
  • To assess the feasibility of developing a vaccine protective against all HCV strains.

Main Methods:

  • Chimpanzees were infected with genotype 1 HCV and subsequently rechallenged with different HCV genotypes (4, 2/3 mixture, and a 1/2/3/4 mixture).

Related Experiment Videos

  • Viremia levels and duration were compared between primary and rechallenge infections.
  • Intrahepatic transcripts of interferon-stimulated genes, gamma interferon, and Mig (a T-cell chemokine) were analyzed.

    • Main Results:

    • Recovery from genotype 1 HCV infection protected chimpanzees against rechallenge with diverse genotypes, significantly reducing viremia.
    • Conserved epitopes between genotypes appear to play a critical role in this cross-genotype immunity.
    • Rechallenge infections rapidly increased interferon-stimulated gene transcripts, even with apparent sterilizing immunity, and were associated with increased gamma interferon and Mig transcripts.

    Conclusions:

    • Cross-genotype immunity to HCV can be induced in chimpanzees, demonstrating protection against genetically diverse strains.
    • The findings support the crucial role of conserved epitopes in eliciting broad adaptive immunity against HCV.
    • This study provides strong evidence for the feasibility of developing a universal vaccine protective against all HCV strains.